CLINICAL_TRIALS
trial_result
· 2010-05-19
Clinical Trial Update: Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer [Phase 2]
Summary
An open-label Phase 2 trial evaluated SU011248 in combination with trastuzumab for metastatic breast cancer; results were posted in May 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2010-05-19